Literature DB >> 21425156

Diabetes and risk of bladder cancer: evidence from a case-control study in New England.

Todd MacKenzie1, Michael S Zens, Assiamira Ferrara, Alan Schned, Margaret R Karagas.   

Abstract

BACKGROUND: Diabetes is an emerging public health issue in the US, affecting 11% of Americans over the age of 20, with long-term complications that include cardiovascular disease, retinopathy, neuropathy, and nephropathy. A recent meta-analysis found that bladder cancer incidence was approximately 40% higher in individuals with diabetes; however, few studies considered duration or type of therapy and had limited adjustment for potentially confounding factors.
METHODS: To further investigate the potential role of diabetes in risk of bladder cancer, the authors analyzed data from a case-control study conducted in New Hampshire in which patients with bladder cancer, and controls sampled from the population, completed an interview regarding history of diabetes, cigarette smoking history, height, weight, and history of urinary tract infections.
RESULTS: The study consisted of 331 cases and 263 controls on whom information regarding diabetes was ascertained. History of diabetes was related to an increased bladder cancer risk (adjusted odds ratio = 2.2, 95% CI, 1.3 to 3.8). The association was strongest in those who had diabetes for the longest duration (OR for 16 or more years = 3.6, 1.1 to 11.2) and in those taking oral hypoglycemic medications (OR = 3.3, 1.5 to 7.1).
CONCLUSIONS: Our findings support an association between bladder cancer incidence and diabetes, and further suggest that the risk may be greater among patients taking oral hypoglycemics and those with diabetes of longer duration.
Copyright © 2010 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21425156      PMCID: PMC3117102          DOI: 10.1002/cncr.25641

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  19 in total

1.  Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure.

Authors:  Yuji Okura; Lynn H Urban; Douglas W Mahoney; Steven J Jacobsen; Richard J Rodeheffer
Journal:  J Clin Epidemiol       Date:  2004-10       Impact factor: 6.437

Review 2.  Diabetes mellitus type 2 - an independent risk factor for cancer?

Authors:  V A Grote; S Becker; R Kaaks
Journal:  Exp Clin Endocrinol Diabetes       Date:  2010-02-01       Impact factor: 2.949

3.  Fasting serum glucose level and cancer risk in Korean men and women.

Authors:  Sun Ha Jee; Heechoul Ohrr; Jae Woong Sull; Ji Eun Yun; Min Ji; Jonathan M Samet
Journal:  JAMA       Date:  2005-01-12       Impact factor: 56.272

Review 4.  Diabetes and cancer.

Authors:  Paolo Vigneri; Francesco Frasca; Laura Sciacca; Giuseppe Pandini; Riccardo Vigneri
Journal:  Endocr Relat Cancer       Date:  2009-07-20       Impact factor: 5.678

5.  Urinary tract infection and risk of bladder cancer.

Authors:  A F Kantor; P Hartge; R N Hoover; A S Narayana; J W Sullivan; J F Fraumeni
Journal:  Am J Epidemiol       Date:  1984-04       Impact factor: 4.897

6.  Diabetes: diabetes therapy and cancer risk.

Authors:  Riccardo Vigneri
Journal:  Nat Rev Endocrinol       Date:  2009-12       Impact factor: 43.330

7.  Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men.

Authors:  Susanna C Larsson; Swen-Olof Andersson; Jan-Erik Johansson; Alicja Wolk
Journal:  Eur J Cancer       Date:  2008-08-15       Impact factor: 9.162

Review 8.  Diabetes mellitus and urinary tract infection: epidemiology, pathogenesis and proposed studies in animal models.

Authors:  Swaine L Chen; Sara L Jackson; Edward J Boyko
Journal:  J Urol       Date:  2009-12       Impact factor: 7.450

9.  Rosiglitazone, a PPAR gamma agonist: potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers.

Authors:  Ronald A Lubet; Susan M Fischer; Vernon E Steele; M Margaret Juliana; Renee' Desmond; Clinton J Grubbs
Journal:  Int J Cancer       Date:  2008-11-15       Impact factor: 7.396

10.  Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study.

Authors:  G David Batty; Martin J Shipley; Michael Marmot; George Davey Smith
Journal:  Cancer Causes Control       Date:  2004-11       Impact factor: 2.506

View more
  28 in total

1.  Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study.

Authors:  Ronac Mamtani; Kevin Haynes; Warren B Bilker; David J Vaughn; Brian L Strom; Karen Glanz; James D Lewis
Journal:  J Natl Cancer Inst       Date:  2012-08-09       Impact factor: 13.506

Review 2.  Addressing limitations in observational studies of the association between glucose-lowering medications and all-cause mortality: a review.

Authors:  Elisabetta Patorno; Elizabeth M Garry; Amanda R Patrick; Sebastian Schneeweiss; Victoria G Gillet; Olesya Zorina; Dorothee B Bartels; John D Seeger
Journal:  Drug Saf       Date:  2015-03       Impact factor: 5.606

3.  Obesity, Diabetes and Cancer: A Mechanistic Perspective.

Authors:  V Cifarelli; S D Hursting
Journal:  Int J Diabetol Vasc Dis Res       Date:  2015-09-28

4.  Diabetes and risk of bladder cancer among postmenopausal women in the Iowa Women's Health Study.

Authors:  Anna E Prizment; Kristin E Anderson; Jian-Min Yuan; Aaron R Folsom
Journal:  Cancer Causes Control       Date:  2013-01-08       Impact factor: 2.506

Review 5.  Diabetes and cancer I: risk, survival, and implications for screening.

Authors:  Adedayo A Onitilo; Jessica M Engel; Ingrid Glurich; Rachel V Stankowski; Gail M Williams; Suhail A Doi
Journal:  Cancer Causes Control       Date:  2012-05-03       Impact factor: 2.506

6.  Modeling temporal relationships in large scale clinical associations.

Authors:  David A Hanauer; Naren Ramakrishnan
Journal:  J Am Med Inform Assoc       Date:  2012-09-27       Impact factor: 4.497

7.  Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan.

Authors:  C-H Tseng
Journal:  Diabetologia       Date:  2011-05-05       Impact factor: 10.122

Review 8.  Scientific Evidence and Controversies About Pioglitazone and Bladder Cancer: Which Lessons Can Be Drawn?

Authors:  Jean-Luc Faillie; Pierre Petit; Jean-Louis Montastruc; Dominique Hillaire-Buys
Journal:  Drug Saf       Date:  2013-09       Impact factor: 5.606

9.  Impact of oral hypoglycemic agents on mortality among diabetic patients with non-muscle-invasive bladder cancer: A populationbased analysis.

Authors:  Patrick O Richard; Ardalan E Ahmad; Shaheena Bashir; Alexandre Zlotta; Bimal Bhindi; Ricardo Leao; Madhur Nayan; Aza Mohammed; Neil E Fleshner; Girish S Kulkarni
Journal:  Can Urol Assoc J       Date:  2018-02-23       Impact factor: 1.862

Review 10.  Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis of observational studies.

Authors:  Hong Fang; Baodong Yao; Yujie Yan; Huilin Xu; Yinan Liu; Hongmei Tang; Jie Zhou; Lili Cao; Weijie Wang; Jinling Zhang; Liyun Zhao; Xi Chen; Fen Zhang; Yanping Zhao
Journal:  Diabetes Technol Ther       Date:  2013-11       Impact factor: 6.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.